(Q46944928)

English

The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment

scientific article published on 14 February 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16478753

The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment (English)

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16478753

extrapyramidal symptoms

1 reference

based on heuristic

inferred from title

author name string

Blanka Kores Plesnicar

1

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16478753

Bojan Zalar

2

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16478753

Katja Breskvar

3

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16478753

Vita Dolzan

4

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16478753

language of work or name

0 references

publication date

14 February 2006

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16478753

Journal of Psychopharmacology

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16478753

20

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16478753

829-833

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16478753

6

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16478753

The impact of the CYP2D6 polymorphism on haloperidol pharmacokinetics and on the outcome of haloperidol treatment.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106062894

21 January 2018

Debrisoquine 4-hydroxylase (CYP2D6) genetic polymorphisms and susceptibility to schizophrenia in Chinese patients from Taiwan

1 reference

https://api.crossref.org/works/10.1177%2F0269881106062894

21 January 2018

No association between schizophrenia and polymorphisms within the genes for debrisoquine 4-hydroxylase (CYP2D6) and the dopamine transporter (DAT).

1 reference

https://api.crossref.org/works/10.1177%2F0269881106062894

21 January 2018

Human CYP2D6 gene polymorphism in Slovene cancer patients and healthy controls

1 reference

https://api.crossref.org/works/10.1177%2F0269881106062894

21 January 2018

Cytochrome P450 II D6 gene polymorphisms and the neuroleptic-induced extrapyramidal symptoms in Japanese schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106062894

21 January 2018

Maintenance therapy with zuclopenthixol decanoate: associations between plasma concentrations, neurological side effects and CYP2D6 genotype

1 reference

https://api.crossref.org/works/10.1177%2F0269881106062894

21 January 2018

Pharmacogenetics of psychotropic drug response

1 reference

https://api.crossref.org/works/10.1177%2F0269881106062894

21 January 2018

A simple salting out procedure for extracting DNA from human nucleated cells

1 reference

https://api.crossref.org/works/10.1177%2F0269881106062894

21 January 2018

Cellular localization and regional distribution of CYP2D6 mRNA and protein expression in human brain

1 reference

https://api.crossref.org/works/10.1177%2F0269881106062894

21 January 2018

Debrisoquine 4-hydroxylase (CYP2D) locus and possible susceptibility to schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881106062894

21 January 2018

Genetic polymorphisms for drug metabolism (CYP2D6) and tardive dyskinesia in schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881106062894

21 January 2018

Non-functional CYP2D6 alleles and risk for neuroleptic-induced movement disorders in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1177%2F0269881106062894

21 January 2018

Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification

1 reference

https://api.crossref.org/works/10.1177%2F0269881106062894

21 January 2018

Identifiers

10.1177/0269881106062894

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16478753

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16478753

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46944928&oldid=2139362717"